Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;13(1):569-577.
doi: 10.1080/21505594.2022.2047506.

Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients

Affiliations

Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients

Asmaa M Zahran et al. Virulence. 2022 Dec.

Abstract

We aimed to determine the levels of follicular helper T (Tfh) and follicular regulatory T (Tfr) cells in COVID-19 patients and determine whether their levels correlated with disease severity and presence of hyperglycemia. This study was carried out in 34 hospitalized COVID-19 patients and 20 healthy controls. Levels of total circulating Tfh, inducible T-cell costimulator (ICOS)+ activated Tfh, and Tfr cells were assessed in all participants by flow cytometry. Total CD4+CXCR5+ Tfh cells and ICOS+Foxp3-activated Tfh cells increased and ICOS+Foxp3+ Tfr cells decreased in COVID-19 patients, especially in diabetic patients and those with severe disease. Activated ICOS+ Tfh cells were directly correlated with lactate dehydrogenase, D-dimer, ferritin, and respiratory rate and inversely correlated with the partial pressure of carbon dioxide. COVID-19 is associated with marked activation of Tfh cells and a profound drop in Tfr cells, especially in severe and diabetic patients. Future studies on expanded cohorts of patients are needed to clarify the relationship between SARS-CoV-2 and acute-onset diabetes.

Keywords: COVID-19; follicular helper T; follicular regulatory T; hyperglycemia.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
A schematic flow chart of the study protocol.
Figure 2.
Figure 2.
Flow cytometry gating strategy of follicular helper T cells (Tfh) and follicular regulatory T cells (Tfr) using FACSDiva software (Becton Dickinson Biosciences, USA).
Figure 3.
Figure 3.
Comparison of the frequencies of follicular helper (Tfh) and follicular regulatory T (Tfr) cells between COVID-19 patients and controls (p-value*** <.0001, ** <.01, ns=not significant). Percentages of ICOS+ and ICOS- cells were calculated from CD4+CXCR5+ Tfh cells.
Figure 4.
Figure 4.
Comparison of the percentages of follicular helper (Tfh) and follicular regulatory T (Tfr) cells between severe and non-severe cases of COVID-19 (p-value: *** <.0001, ** <.01, ns=not significant). Percentages of ICOS+ and ICOS- cells were calculated from CD4+CXCR5+ Tfh cells.
Figure 5.
Figure 5.
A heat map showing the levels of activated Tfh cells (Cd4+cxcr5+icos+foxp3-), resting Tfh (Cd4+cxcr5+icos-Foxp3-), and Tfr cells (Cd4+cxcr5+icos+foxp3+) in relation with clinical and laboratory findings in COVID-19 patients. as shown, most of the CD4+CXCR5+ Tfh cells were activated (Icos+) in severe cases and the increase in its level was associated with higher LDH, D-dimer, and ferritin, as well as respiratory rate, and lower PaCo2. Resting Tfh and Tfr cells showed opposite relations with the laboratory indices of severity.
Figure 6.
Figure 6.
Comparison of the percentages of follicular helper (Tfh) and follicular regulatory T (Tfr) cells between diabetic and non-diabetic cases of COVID-19 and healthy controls (p-value: *** <.0001, ** <.01, ns=not significant). Percentages of ICOS+ and ICOS- cells were calculated from CD4+CXCR5+ Tfh cells.

References

    1. Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. - PMC - PubMed
    1. Sherif M, Saad K, Elgohary G, AbdElHaffez A, El-Aziz Abd N, Is COVID-19 a Systemic Disease? Coronaviruses 2021; 2(5): e060521189167. 10.2174/2666796701999201216101914 - DOI
    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. - PMC - PubMed
    1. Hale JS, Youngblood B, Latner DR, et al. Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection. Immunity. 2013;38(4):805–817. - PMC - PubMed
    1. Cannons JL, Lu KT, Schwartzberg PL.. T follicular helper cell diversity and plasticity. Trends Immunol. 2013;34(5):200–207. - PMC - PubMed

Publication types